← Back to Search

Educational materials for TissueCypher for Barrett's Esophagus

N/A
Waitlist Available
Research Sponsored by Qure Healthcare, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

This trial will study how different information affects doctors' diagnostic and treatment decisions for simulated patients. The results could improve patient care by showing what works best.

Eligible Conditions
  • Barrett's Esophagus
  • Gastrointestinal Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CPV-measured cost savings
CPV-measured evidence based management decisions
Clinical Performance and Value (CPV)-measured change in physician behavior
Secondary outcome measures
CPV-measured baseline levels of variation
CPV-measured use case analysis

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group 2Experimental Treatment1 Intervention
Intervention group 2 receives educational materials about the TissueCypher diagnostic test. These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report. This intervention group then gets to decide whether or not they want to use the TissueCypher test results for their simulated patients.
Group II: Intervention Group 1Experimental Treatment1 Intervention
Intervention group 1 receives educational materials about the TissueCypher diagnostic test. These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report. This intervention group is then forced to use the test results in treating their simulated patients.
Group III: Control GroupActive Control1 Intervention
The control group does not receive educational materials about the TissueCypher diagnostic test and will treat their simulated patients with the current standard of care tools.

Find a Location

Who is running the clinical trial?

Qure Healthcare, LLCLead Sponsor
21 Previous Clinical Trials
3,675 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Clinical Utility Evidence for TissueCypher®
2021. "Clinical Utility Evidence for TissueCypher®". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05200325.
~71 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top